January 27, 2022 – The CONDOR consortium, led by Pr. Antoine Italiano of the Bergonié Institute (Bordeaux, France) is one of the 17 national awardees in the fifth call for projects in Hospital-University Research in Health (RHU5), selected from the 89 applications submitted. This €30M ($34M) project will benefit fro.
Le Lions Club Royan Côte Atlantique fait un don de 3 000 euros à l'institut Bergonié sudouest.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sudouest.fr Daily Mail and Mail on Sunday newspapers.
The German-French Cooperation Programme GENESIS describes the complex structure of the interstellar medium using a new mathematical method. The dispersion of interstellar turbulence in gas clouds before star formation unfolds in a cosmically small space.
Château Petrus, vin star d'une vente aux enchères exceptionnelle à Bordeaux sudouest.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sudouest.fr Daily Mail and Mail on Sunday newspapers.
Provided by Business Wire
Mar 1, 2021 6:30 AM UTC
Transgene and BioInvent Have Enrolled First Patient in Phase I/IIa Trial of Novel Oncolytic Virus BT-001 in Solid Tumors
Regulatory News:
Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that the first patient in a Phase I/IIa clinical trial of the novel dual mechanism-of-action oncolytic Vaccinia virus BT-001 has been enrolled at Institut Bergonié (Bordeaux, France).